Bioservo Technologies Past Earnings Performance
Past criteria checks 0/6
Bioservo Technologies's earnings have been declining at an average annual rate of -15.8%, while the Medical Equipment industry saw earnings growing at 6.5% annually. Revenues have been declining at an average rate of 11.8% per year.
Key information
-15.8%
Earnings growth rate
9.3%
EPS growth rate
| Medical Equipment Industry Growth | 6.2% |
| Revenue growth rate | -11.8% |
| Return on equity | -121.8% |
| Net Margin | -395.7% |
| Next Earnings Update | 20 Feb 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Bioservo Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 12 | -47 | 47 | 0 |
| 30 Jun 23 | 11 | -48 | 49 | 0 |
| 31 Mar 23 | 15 | -48 | 52 | 0 |
| 31 Dec 22 | 14 | -50 | 54 | 0 |
| 30 Sep 22 | 15 | -43 | 48 | 0 |
| 30 Jun 22 | 17 | -39 | 44 | 0 |
| 31 Mar 22 | 13 | -38 | 41 | 0 |
| 31 Dec 21 | 11 | -35 | 36 | 0 |
| 30 Sep 21 | 7 | -34 | 36 | 0 |
| 30 Jun 21 | 5 | -34 | 35 | 0 |
| 31 Mar 21 | 10 | -28 | 32 | 0 |
| 31 Dec 20 | 14 | -26 | 34 | 0 |
| 30 Sep 20 | 22 | -25 | 37 | 0 |
| 30 Jun 20 | 23 | -24 | 39 | 0 |
| 31 Mar 20 | 25 | -25 | 42 | 0 |
| 31 Dec 19 | 24 | -23 | 40 | 0 |
| 30 Sep 19 | 23 | -27 | 37 | 0 |
| 30 Jun 19 | 21 | -28 | 36 | 0 |
| 31 Mar 19 | 17 | -27 | 33 | 0 |
| 31 Dec 18 | 16 | -28 | 31 | 0 |
| 30 Sep 18 | 15 | -23 | 31 | 0 |
| 30 Jun 18 | 14 | -21 | 28 | 0 |
| 31 Mar 18 | 12 | -22 | 27 | 0 |
| 31 Dec 17 | 12 | -19 | 25 | 0 |
| 30 Sep 17 | 11 | -17 | 24 | 0 |
| 30 Jun 17 | 11 | -16 | 22 | 0 |
| 31 Mar 17 | 12 | -12 | 20 | 0 |
| 31 Dec 16 | 11 | -13 | 20 | 0 |
| 31 Dec 15 | 11 | -7 | 16 | 0 |
| 31 Dec 14 | 8 | -4 | 12 | 0 |
Quality Earnings: BIOS is currently unprofitable.
Growing Profit Margin: BIOS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOS is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.
Accelerating Growth: Unable to compare BIOS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIOS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10.8%).
Return on Equity
High ROE: BIOS has a negative Return on Equity (-121.81%), as it is currently unprofitable.